These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26105382)

  • 1. PP059. Angiogenic factors and risk of preeclampsia related adverse outcomes in twin pregnancies.
    Rana S; Hacker M; Merport A; Salahuddin S; Verlohren S; Perschel F; Karumanchi SA
    Pregnancy Hypertens; 2012 Jul; 2(3):273-4. PubMed ID: 26105382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
    Salahuddin S; Wenger JB; Zhang D; Thadhani R; Karumanchi SA; Rana S
    Hypertens Pregnancy; 2016 Aug; 35(3):330-45. PubMed ID: 27028795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.
    Rana S; Hacker MR; Modest AM; Salahuddin S; Lim KH; Verlohren S; Perschel FH; Karumanchi SA
    Hypertension; 2012 Aug; 60(2):451-8. PubMed ID: 22753210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
    March MI; Geahchan C; Wenger J; Raghuraman N; Berg A; Haddow H; Mckeon BA; Narcisse R; David JL; Scott J; Thadhani R; Karumanchi SA; Rana S
    PLoS One; 2015; 10(5):e0126815. PubMed ID: 25965397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients].
    Husse S; Gottschlich A; Schrey S; Stepan H; Hoffmann J
    Z Geburtshilfe Neonatol; 2014 Feb; 218(1):34-41. PubMed ID: 24595913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.
    Rana S; Powe CE; Salahuddin S; Verlohren S; Perschel FH; Levine RJ; Lim KH; Wenger JB; Thadhani R; Karumanchi SA
    Circulation; 2012 Feb; 125(7):911-9. PubMed ID: 22261192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders.
    Engels T; Pape J; Schoofs K; Henrich W; Verlohren S
    Hypertens Pregnancy; 2013 Nov; 32(4):459-73. PubMed ID: 23957293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PP176. SFLT-1: A possibility of precocious diagnosis of preeclampsia.
    Olmos CS; Macedo MA; Pereira RM; Augusto V; Garcia JM; Panico VJ; Souza EV; Sato JL; Saito M; Sousa FL; Sass N
    Pregnancy Hypertens; 2012 Jul; 2(3):335-6. PubMed ID: 26105497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population.
    Kumar N; Das V; Agarwal A; Agrawal S
    AJOG Glob Rep; 2023 May; 3(2):100177. PubMed ID: 36911235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OS096. Characteristics of hypertensive disorders in twin versus singleton pregnancies.
    Foo JY; Mangos G; Brown M
    Pregnancy Hypertens; 2012 Jul; 2(3):230-1. PubMed ID: 26105310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
    Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
    BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia.
    Moore AG; Young H; Keller JM; Ojo LR; Yan J; Simas TA; Maynard SE
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2651-7. PubMed ID: 22861812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sFlt1/PlGF among patients with suspected preeclampsia when considering hypertensive status.
    Patel E; Suresh S; Mueller A; Bisson C; Zhu K; Verlohren S; von Dadelszen P; Magee L; Rana S
    AJOG Glob Rep; 2024 Aug; 4(3):100359. PubMed ID: 39005612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia.
    Rana S; Cerdeira AS; Wenger J; Salahuddin S; Lim KH; Ralston SJ; Thadhani RI; Karumanchi SA
    PLoS One; 2012; 7(10):e48259. PubMed ID: 23110221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PP178. Antenatal sFlt1 and PlGF levels at 20-28weeks of gestation for prediction of the occurrence of preeclampsia: A preliminary report.
    Jantarasaengaram S; Tansatit T; Samkhoompim N
    Pregnancy Hypertens; 2012 Jul; 2(3):337. PubMed ID: 26105499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INOVASIA Study: A Randomized Open Controlled Trial to Evaluate Pravastatin to Prevent Preeclampsia and Its Effects on sFlt1/PlGF Levels.
    Akbar MIA; Yosediputra A; Pratama RE; Fadhilah NL; Sulistyowati S; Amani FZ; Ernawati E; Dachlan EG; Angsar MD; Dekker G
    Am J Perinatol; 2024 Feb; 41(3):300-309. PubMed ID: 34666379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.